Table 2. Factors associated with diagnostic resolution within 365 days in an adjusted Generalized Linear Mixed Model: Northwest Tribal Cancer Navigation Study.
| Variable | Referent | Median T1a in days (range) |
Adjusted ORb (95% CIc) |
p- value |
|---|---|---|---|---|
|
| ||||
| Study Arm | Control Participants (n=1036) | 42 (1 – 1240) | ||
|
| ||||
| Navigated Participants (n=151) | 37 (1 – 1002) | 3.61 (1.47, 8.88) | 0.013 | |
|
| ||||
| Cancer Site | Cervical Abnormality (n=298) | 107 (3 – 1240) | ||
|
| ||||
| Breast Abnormality (n=400) | 18 (1 – 998) | 4.19 (2.88, 6.10) | <.0001 | |
| Colorectal Abnormality (n=234) | 42 (1 – 1002) | 1.92 (1.29, 2.86) | 0.0024 | |
| Prostate Abnormality (n=70) | 75 (5 – 1078) | 0.77 (0.42, 1.44) | <.4065 | |
| Other Cancer Abnormality (n=185) | 34 (1 – 467) | 3.75 (2.13, 6.63) | <.0001 | |
|
| ||||
| Health Care Coverage | IHS Direct Only (n=132) | 68 (1 – 713) | ||
|
| ||||
| IHSd Direct and CHSe Only (n=317) | 35 (1 – 848) | 2.07 (1.26, 3.40) | 0.006 | |
| Other Combinationsf (n=322) | 41 (1 – 1240) | 1.96 (1.19, 3.24) | 0.011 | |
| Private Insurance (n=414) | 41 (1 – 1017) | 2.47 (1.52, 4.01) | 0.0008 | |
|
| ||||
| Cancer Stage | Non Cancer Cases (n=1019) | 42 (1 – 1240) | ||
|
| ||||
| Early Stage (No Metastasis) (n=75) | 47 (2 – 939) | 6.32 (2.34, 16.7) | 0.001 | |
| Regional/Distant Spread (n=93) | 24 (1 – 1002) | 11.3 (2.33, 55.0) | 0.005 | |
T1=0 and pre-cancerous patients are excluded in outcome analysis; subjects with no definitive diagnosis are included in more than one year group.
a
T1 is number of days from abnormal cancer related finding to definitive diagnosis
b
OR= Odds Ratio
c
CI=Confidence Interval
d
IHS =Indian Health service
e
CHS=Contract Health Service
f
Other Combinations include Medicare/Medicaid and Military health or other State sponsored health plans but exclude private insurance